\-\ Texto\\:\\ \ \(0\)\
\-\ bone\\ scan\\:\\ flow\\ and\\ blood\\ pool\\ images\\ over\\ the\\ anterior\\ thighs\\ demonstrate\\ markedly\\ increased\\ tracer\\ accumulation\\ in\\ the\\ right\\ distal\\ femur\\.\\ these\\ images\\ are\\ made\\ as\\ technetium\\ phosphate\\ tracer\\ is\\ injected\\ intravenously\\ and\\ immediately\\ thereafter\\,\\ and\\ hence\\ reflect\\ blood\\ flow\\ \\(flow\\ phase\\)\\ and\\ initial\\ blood\\ distribution\\ of\\ tracer\\ \\(blood\\ pool\\ phase\\)\\.\\ in\\ this\\ patient\\ the\\ increased\\ tracer\\ accumulation\\ indicates\\ increased\\ regional\\ blood\\ flow\\ in\\ the\\ right\\ distal\\ femur\\.\ \(0\)\
\-\ \\	bone\\ phase\\ images\\ are\\ taken\\ several\\ hours\\ after\\ initial\\ injection\\,\\ and\\ they\\ reflect\\ the\\ amount\\ of\\ tracer\\ retained\\ by\\ bone\\ after\\ technetium\\ has\\ been\\ flushed\\ out\\ of\\ the\\ soft\\ tissues\\.\\ for\\ reasons\\ not\\ fully\\ understood\\,\\ technetium\\ tracer\\ is\\ retained\\ most\\ strongly\\ by\\ bone\\ secreting\\ osteoid\\.\\ hence\\ any\\ disease\\ entity\\ which\\ stimulates\\ bone\\ growth\\ \\(including\\ reactive\\ bone\\)\\ will\\ produce\\ an\\ abnormal\\ focal\\ increase\\ in\\ tracer\\ accumulation\\.\\ this\\ patient\\'s\\ bone\\ phase\\ images\\ demonstrate\\ a\\ focal\\ \\"hot\\ spot\\"\\ in\\ the\\ same\\ area\\ as\\ the\\ flow\\ and\\ blood\\ pool\\ images\\,\\ indicating\\ new\\ bone\\ formation\\.\ \(0\)\
\-\ \\	indium\\ wbc\\ study\\:\\ this\\ study\\ reveals\\ an\\ area\\ of\\ focally\\ increased\\ activity\\ in\\ the\\ right\\ distal\\ femur\\ which\\ corresponds\\ with\\ the\\ bone\\ scan\\ images\\.\\ these\\ images\\ are\\ produced\\ by\\ labeling\\ the\\ patient\\'s\\ wbcs\\ with\\ indium\\,\\ and\\ then\\ reinjecting\\ the\\ cells\\ to\\ determine\\ their\\ distribution\\ in\\ the\\ body\\.\\ the\\ focal\\ increase\\ in\\ wbcs\\ in\\ abnormal\\ areas\\ is\\ fairly\\ specific\\ evidence\\ for\\ infection\\,\\ and\\ when\\ correlated\\ with\\ an\\ abnormal\\ bone\\ scan\\,\\ is\\ fairly\\ specific\\ for\\ osteomyelitis\\.\ \(0\)\
\-\ right\\ distal\\ femur\\ osteomyelitis\ \(1\)\
\-\ 49yo\\ caucasian\\ female\\ with\\ a\\ past\\ history\\ of\\ right\\ distal\\ femur\\ osteomyelitis\\ 10\\ years\\ ago\\.\\ the\\ patient\\ was\\ treated\\ at\\ that\\ time\\ and\\ was\\ symptom\\ free\\ until\\ 3\\ months\\ ago\\,\\ when\\ she\\ began\\ to\\ experience\\ right\\ thigh\\ pain\\.\\ approximately\\ one\\ week\\ ago\\ the\\ thigh\\ became\\ erythematous\\,\\ and\\ began\\ to\\ drain\\ muco\\-purulent\\ material\\ from\\ newly\\ formed\\ sinus\\ tracts\\.\ \(0\)\
\-\ in\\ the\\ majority\\ of\\ patients\\ with\\ osteomyelitis\\,\\ bone\\ imaging\\ studies\\ become\\ positive\\ within\\ two\\ to\\ three\\ days\\ after\\ the\\ onset\\ of\\ symptoms\\,\\ whereas\\ plain\\ x\\-rays\\ typically\\ do\\ not\\ become\\ abnormal\\ for\\ ten\\ to\\ fourteen\\ days\\.\\ for\\ these\\ reasons\\,\\ bone\\ imaging\\ has\\ become\\ an\\ important\\ tool\\ in\\ the\\ early\\ diagnosis\\ of\\ osteomyelitis\\.\\ it\\ is\\ particularly\\ useful\\ when\\ there\\ is\\ doubt\\ regarding\\ the\\ exact\\ diagnosis\\,\\ or\\ when\\ there\\ is\\ doubt\\ regarding\\ the\\ exact\\ site\\ of\\ or\\ extent\\ of\\ infection\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ tracer\\:\\ 0\\.3587496839242769\ \(0\)\
\-\ bone\\:\\ 0\\.2919027379755704\ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.1921736267742275\ \(0\)\
\-\ the\\:\\ 0\\.18680944037565345\ \(0\)\
\-\ femur\\:\\ 0\\.1828749316226472\ \(0\)\
\-\ technetium\\:\\ 0\\.16237159982477578\ \(0\)\
\-\ blood\\:\\ 0\\.1553485006560688\ \(0\)\
\-\ phase\\:\\ 0\\.15259366158868337\ \(0\)\
\-\ flow\\:\\ 0\\.14847320750064608\ \(0\)\
\-\ images\\:\\ 0\\.1443544050231772\ \(0\)\
\-\ pool\\:\\ 0\\.14037277655294028\ \(0\)\
\-\ distal\\:\\ 0\\.12951571395710482\ \(0\)\
\-\ accumulation\\:\\ 0\\.12922591486938195\ \(0\)\
\-\ in\\:\\ 0\\.1219955976757061\ \(0\)\
\-\ doubt\\:\\ 0\\.12092320146044137\ \(0\)\
\-\ become\\:\\ 0\\.11868627596575618\ \(0\)\
\-\ reflect\\:\\ 0\\.11333433773572815\ \(0\)\
\-\ indium\\:\\ 0\\.11008877341736377\ \(0\)\
\-\ wbcs\\:\\ 0\\.10824773321651718\ \(0\)\
\-\ when\\:\\ 0\\.10771998535596261\ \(0\)\
\-\ abnormal\\:\\ 0\\.1071366315954473\ \(0\)\
\-\ hence\\:\\ 0\\.10249990969265055\ \(0\)\
\-\ retained\\:\\ 0\\.09975060215350705\ \(0\)\
\-\ ago\\:\\ 0\\.09785865323876175\ \(0\)\
\-\ exact\\:\\ 0\\.09785363783000396\ \(0\)\
\-\ increased\\:\\ 0\\.09643090408700714\ \(0\)\
\-\ reasons\\:\\ 0\\.09463601056216617\ \(0\)\
\-\ fairly\\:\\ 0\\.09358185103529353\ \(0\)\
\-\ regarding\\:\\ 0\\.09358185103529353\ \(0\)\
\-\ and\\:\\ 0\\.09212286398582724\ \(0\)\
\-\ right\\:\\ 0\\.08868429906134392\ \(0\)\
\-\ thigh\\:\\ 0\\.0877038787527686\ \(0\)\
\-\ of\\:\\ 0\\.08724464001469145\ \(0\)\
\-\ is\\:\\ 0\\.08546323180569239\ \(0\)\
\-\ began\\:\\ 0\\.08291825284131532\ \(0\)\
\-\ focal\\:\\ 0\\.08000048131294434\ \(0\)\
\-\ scan\\:\\ 0\\.07934968887487807\ \(0\)\
\-\ distribution\\:\\ 0\\.0756362771980686\ \(0\)\
\-\ these\\:\\ 0\\.07552603279482879\ \(0\)\
\-\ increase\\:\\ 0\\.07157683628113659\ \(0\)\
\-\ flushed\\:\\ 0\\.07129602877329827\ \(0\)\
\-\ reinjecting\\:\\ 0\\.07129602877329827\ \(0\)\
\-\ 49yo\\:\\ 0\\.07129602877329827\ \(0\)\
\-\ an\\:\\ 0\\.06819174667812668\ \(0\)\
\-\ stimulates\\:\\ 0\\.06812716171231724\ \(0\)\
\-\ specific\\:\\ 0\\.06756567476447572\ \(0\)\
\-\ for\\:\\ 0\\.06756203091806756\ \(0\)\
\-\ after\\:\\ 0\\.0648821088481816\ \(0\)\
\-\ intravenously\\:\\ 0\\.06413486136220839\ \(0\)\
\-\ fourteen\\:\\ 0\\.06413486136220839\ \(0\)\
\-\ initial\\:\\ 0\\.05981437355360758\ \(0\)\
\-\ labeling\\:\\ 0\\.059541080629797384\ \(0\)\
\-\ study\\:\\ 0\\.05946571726312138\ \(0\)\
\-\ patient\\:\\ 0\\.05800090634096395\ \(0\)\
\-\ area\\:\\ 0\\.057761489976057956\ \(0\)\
\-\ phosphate\\:\\ 0\\.057292733669239634\ \(0\)\
\-\ by\\:\\ 0\\.05679607370993404\ \(0\)\
\-\ days\\:\\ 0\\.05644443545226415\ \(0\)\
\-\ thighs\\:\\ 0\\.05608798632609187\ \(0\)\
\-\ tool\\:\\ 0\\.05608798632609187\ \(0\)\
\-\ to\\:\\ 0\\.055726831748500114\ \(0\)\
\-\ understood\\:\\ 0\\.05554878027968854\ \(0\)\
\-\ secreting\\:\\ 0\\.05554878027968854\ \(0\)\
\-\ thereafter\\:\\ 0\\.054570581778696926\ \(0\)\
\-\ infection\\:\\ 0\\.053859992677981305\ \(0\)\
\-\ correlated\\:\\ 0\\.05370131030653004\ \(0\)\
\-\ ten\\:\\ 0\\.05330043331913079\ \(0\)\
\-\ focally\\:\\ 0\\.05220813953918556\ \(0\)\
\-\ tracts\\:\\ 0\\.05220813953918556\ \(0\)\
\-\ hot\\:\\ 0\\.0515564799295797\ \(0\)\
\-\ newly\\:\\ 0\\.0515564799295797\ \(0\)\
\-\ are\\:\\ 0\\.05075031445306177\ \(0\)\
\-\ corresponds\\:\\ 0\\.05013156625814975\ \(0\)\
\-\ regional\\:\\ 0\\.04962717268714309\ \(0\)\
\-\ osteoid\\:\\ 0\\.04915336775715813\ \(0\)\
\-\ injected\\:\\ 0\\.048706652586719794\ \(0\)\
\-\ entity\\:\\ 0\\.04849251897799945\ \(0\)\
\-\ formed\\:\\ 0\\.04849251897799945\ \(0\)\
\-\ fully\\:\\ 0\\.04808108778534423\ \(0\)\
\-\ whereas\\:\\ 0\\.047318005281083084\ \(0\)\
\-\ indicates\\:\\ 0\\.046962699197168695\ \(0\)\
\-\ imaging\\:\\ 0\\.04685850578970966\ \(0\)\
\-\ demonstrate\\:\\ 0\\.046353700595942335\ \(0\)\
\-\ diagnosis\\:\\ 0\\.04622179453374824\ \(0\)\
\-\ this\\:\\ 0\\.04595734416857088\ \(0\)\
\-\ produced\\:\\ 0\\.04539437989117177\ \(0\)\
\-\ symptom\\:\\ 0\\.04539437989117177\ \(0\)\
\-\ erythematous\\:\\ 0\\.04525355828301427\ \(0\)\
\-\ strongly\\:\\ 0\\.04484570638412636\ \(0\)\
\-\ produce\\:\\ 0\\.044714352236610945\ \(0\)\
\-\ drain\\:\\ 0\\.04445808705521472\ \(0\)\
\-\ experience\\:\\ 0\\.044333038182590975\ \(0\)\
\-\ became\\:\\ 0\\.04373615373561933\ \(0\)\
\-\ with\\:\\ 0\\.043648384333155495\ \(0\)\
\-\ spot\\:\\ 0\\.04350960489346318\ \(0\)\
\-\ useful\\:\\ 0\\.042564313337105746\ \(0\)\
\-\ indicating\\:\\ 0\\.042178289799481794\ \(0\)\
\-\ particularly\\:\\ 0\\.042084691222033226\ \(0\)\
\-\ determine\\:\\ 0\\.04145912642065766\ \(0\)\
\-\ immediately\\:\\ 0\\.04080059915876076\ \(0\)\
\-\ extent\\:\\ 0\\.04080059915876076\ \(0\)\
\-\ has\\:\\ 0\\.040727348801480455\ \(0\)\
\-\ which\\:\\ 0\\.04054359032232364\ \(0\)\
\-\ majority\\:\\ 0\\.040491038383953584\ \(0\)\
\-\ caucasian\\:\\ 0\\.03962975810655687\ \(0\)\
\-\ markedly\\:\\ 0\\.03936253933149051\ \(0\)\
\-\ injection\\:\\ 0\\.0387927446440655\ \(0\)\
\-\ reactive\\:\\ 0\\.038261683869691074\ \(0\)\
\-\ important\\:\\ 0\\.03776442438206824\ \(0\)\
\-\ material\\:\\ 0\\.03755318482552106\ \(0\)\
\-\ until\\:\\ 0\\.037097790711598584\ \(0\)\
\-\ their\\:\\ 0\\.037000097091979135\ \(0\)\
\-\ do\\:\\ 0\\.0369517044432189\ \(0\)\
\-\ growth\\:\\ 0\\.03676107577794299\ \(0\)\
\-\ site\\:\\ 0\\.035956497474569166\ \(0\)\
\-\ as\\:\\ 0\\.035820195174163086\ \(0\)\
\-\ amount\\:\\ 0\\.035664689100389516\ \(0\)\
\-\ taken\\:\\ 0\\.03562387758308444\ \(0\)\
\-\ there\\:\\ 0\\.035477932207135986\ \(0\)\
\-\ formation\\:\\ 0\\.03534401282319962\ \(0\)\
\-\ same\\:\\ 0\\.03526585829386445\ \(0\)\
\-\ not\\:\\ 0\\.03519968068621103\ \(0\)\
\-\ tissues\\:\\ 0\\.03515007265309948\ \(0\)\
\-\ free\\:\\ 0\\.03470335748266115\ \(0\)\
\-\ made\\:\\ 0\\.03438431776454002\ \(0\)\
\-\ cells\\:\\ 0\\.034349659668698795\ \(0\)\
\-\ hours\\:\\ 0\\.0339782322545859\ \(0\)\
\-\ reveals\\:\\ 0\\.03391255634033328\ \(0\)\
\-\ activity\\:\\ 0\\.03273120137563204\ \(0\)\
\-\ studies\\:\\ 0\\.03270313891171383\ \(0\)\
\-\ sinus\\:\\ 0\\.032214518076240914\ \(0\)\
\-\ early\\:\\ 0\\.032135970803982256\ \(0\)\
\-\ including\\:\\ 0\\.03190495730143374\ \(0\)\
\-\ they\\:\\ 0\\.03185453526973695\ \(0\)\
\-\ then\\:\\ 0\\.031558649290389894\ \(0\)\
\-\ wbc\\:\\ 0\\.0315104060026067\ \(0\)\
\-\ typically\\:\\ 0\\.03129692234921164\ \(0\)\
\-\ was\\:\\ 0\\.03107440829528902\ \(0\)\
\-\ or\\:\\ 0\\.031018439673533973\ \(0\)\
\-\ new\\:\\ 0\\.030842411280067716\ \(0\)\
\-\ areas\\:\\ 0\\.030267961035021575\ \(0\)\
\-\ week\\:\\ 0\\.029985931904477056\ \(0\)\
\-\ three\\:\\ 0\\.029926798801660822\ \(0\)\
\-\ plain\\:\\ 0\\.02941381891343955\ \(0\)\
\-\ positive\\:\\ 0\\.02937712688452132\ \(0\)\
\-\ body\\:\\ 0\\.029340606314307606\ \(0\)\
\-\ out\\:\\ 0\\.02930425560782505\ \(0\)\
\-\ several\\:\\ 0\\.02925004460800831\ \(0\)\
\-\ past\\:\\ 0\\.029019380779418114\ \(0\)\
\-\ any\\:\\ 0\\.028812338531137394\ \(0\)\
\-\ will\\:\\ 0\\.02869404932248597\ \(0\)\
\-\ onset\\:\\ 0\\.028627250729478408\ \(0\)\
\-\ approximately\\:\\ 0\\.028446445051026448\ \(0\)\
\-\ treated\\:\\ 0\\.027762356399853447\ \(0\)\
\-\ years\\:\\ 0\\.027328056462850917\ \(0\)\
\-\ she\\:\\ 0\\.026538492729675518\ \(0\)\
\-\ two\\:\\ 0\\.026475107241888764\ \(0\)\
\-\ time\\:\\ 0\\.02642476640565195\ \(0\)\
\-\ 10\\:\\ 0\\.02606918155418196\ \(0\)\
\-\ been\\:\\ 0\\.025973870765574326\ \(0\)\
\-\ months\\:\\ 0\\.02595022358322398\ \(0\)\
\-\ one\\:\\ 0\\.025525182261504926\ \(0\)\
\-\ evidence\\:\\ 0\\.025304705361273952\ \(0\)\
\-\ patients\\:\\ 0\\.025079709502293168\ \(0\)\
\-\ anterior\\:\\ 0\\.0248918807284588\ \(0\)\
\-\ over\\:\\ 0\\.024789449540006853\ \(0\)\
\-\ symptoms\\:\\ 0\\.02439264412748703\ \(0\)\
\-\ soft\\:\\ 0\\.02373440997743986\ \(0\)\
\-\ most\\:\\ 0\\.023201726884929927\ \(0\)\
\-\ it\\:\\ 0\\.022820808336479446\ \(0\)\
\-\ female\\:\\ 0\\.021512782317451854\ \(0\)\
\-\ within\\:\\ 0\\.020533009561685186\ \(0\)\
\-\ that\\:\\ 0\\.019346836120732774\ \(0\)\
\-\ disease\\:\\ 0\\.018713862444246703\ \(0\)\
\-\ from\\:\\ 0\\.01770600711827683\ \(0\)\
\-\ history\\:\\ 0\\.017032834466176643\ \(0\)\
\-\ at\\:\\ 0\\.016839116176009077\ \(0\)\
\-\ pain\\:\\ 0\\.015953014322234886\ \(0\)\
